๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
70.30
-0.90 (-1.26%)
Nov 19, 2026, 1:30 PM CST

Excelsior Medical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9,7588,7898,5398,2337,1876,573
Revenue Growth
11.05%2.94%3.71%14.56%9.34%-1.53%
Gross Profit
2,1411,8741,7811,6701,5141,374
Operating Income
761.16727.54753.32702.88606.61595.03
Net Income
905.03805.86771.26746.61667.45607.15
Earnings Per Share
4.924.684.484.333.873.52
EPS Growth
5.19%4.46%3.38%11.88%10.16%5.78%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Yaoya Segment
1,3871,5731,5941,2921,028
Excelsior Medical Department
5,4295,2915,2474,6544,373
Arich Enterprise Department
1,5471,2981,1401,018945.66
Other Department
634.26546.46394.17305.51323.59
Adjustment and Elimination
-208.21-169.37-141.21-82.81-97.47
Total
8,7898,5398,2337,1876,573

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4,8253,5345,0483,4063,2293,772
Total Debt
2,1232,1541,4261,442808.58761.99
Net Cash (Debt)
2,7031,3813,6221,9642,4203,010
Net Cash Growth
147.68%-61.88%84.42%-18.85%-19.59%5.90%
Net Cash Per Share
14.688.0121.0311.4014.0417.45

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,507-1,3642,471107.1637.13945.05
Capital Expenditures
-127.44-77.79-114.87-126.37-171.6-164.69
Free Cash Flow
1,379-1,4412,357-19.27465.53780.36
Free Cash Flow Growth
-----40.34%-6.96%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
21.94%21.33%20.86%20.28%21.07%20.90%
Operating Margin
7.80%8.28%8.82%8.54%8.44%9.05%
Pretax Margin
13.24%13.45%13.75%13.90%13.41%13.29%
Profit Margin
9.28%9.17%9.03%9.07%9.29%9.24%
FCF Margin
14.14%-16.40%27.60%-0.23%6.48%11.87%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
4.3004.3003.8003.4473.1532.879
Dividend Per Share Growth
18.82%13.16%10.25%9.31%9.50%-0.00%
Dividend Yield
6.12%5.27%4.64%4.30%5.40%6.08%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.2917.3718.2218.4315.0113.39
Forward PE
-17.0317.8115.7115.7111.84
P/FCF Ratio
9.60-5.96-21.5210.42
PS Ratio
1.361.591.651.671.391.24